Categories: DevelopmentHardwareMedTechProduct
Autonomic Technologies Europe GmbH is a 100% subsidiary of Autonomic Technologies, Inc. (ATI), a medical device company located in the San Francisco Bay Area focused on the development and commercialization of innovative therapies for the treatment of autonomic disorders, particularly severe headache. The company’s initial product, the Pulsant microstimulator, is CE marked in Europe for the treatment of cluster headache. The device is also under an IDE study in the US for the treatment of chronic cluster headache.
Investors 2
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.06.2015 | Series D | $43.2M | - |
| 12.05.2015 | Series D | $38M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 25.06.2015 | Autonomic Technologies Closes $43.2M Series D Financing | Autonomic Technologies, Inc. , a Redwood City, CA-based developer and manufacturer of Pulsante™, a m... | finsmes.co... |
| 12.05.2015 | Autonomic Technologies Closes $38M Series D Financing | Autonomic Technologies™, Inc., a Redwood City, California-based developer and manufacturer of a micr... | finsmes.co... |
| 30.05.2014 | Medtech experts say despite “schizophrenia,” the industry’s ... | “Our product has great value,” he said. “We’re not there yet, but there are some good trends.”
Pane... | medcitynew... |
| 23.10.2013 | Versant Ventures seeks $250M for next medtech venture capita... | Directors who will manage the fund listed on the regulatory filing include CFO Robin Praeger; Bradle... | medcitynew... |
| - | Medtech experts say despite “schizophrenia,” the industry’s ... | The investment climate for the medtech industry has become more cautious, more focused on short-term... | medcitynew... |
| - | Versant Ventures seeks $250M for next medtech venture capita... | Though lots of venture capital for medtech has evaporated, Versant Ventures now seeks $250 million f... | medcitynew... |
Reviews 0
